Federation Des Caisses Desjardins Du Quebec Inmune Bio, Inc. Transaction History
Federation Des Caisses Desjardins Du Quebec
- $19 Billion
- Q1 2025
A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Inmune Bio, Inc. stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 400 shares of INMB stock, worth $1,024. This represents 0.0% of its overall portfolio holdings.
Number of Shares
400
Previous 400
-0.0%
Holding current value
$1,024
Previous $1,000
200.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding INMB
# of Institutions
95Shares Held
6.88MCall Options Held
317KPut Options Held
104K-
Praetorian Pr LLC Rincon, PR865KShares$2.21 Million2.92% of portfolio
-
Vanguard Group Inc Valley Forge, PA848KShares$2.17 Million0.0% of portfolio
-
Black Rock Inc. New York, NY813KShares$2.08 Million0.0% of portfolio
-
Cvi Holdings, LLC Wilmington, DE596KShares$1.53 Million45.87% of portfolio
-
Geode Capital Management, LLC Boston, MA390KShares$998,2230.0% of portfolio
About Inmune Bio, Inc.
- Ticker INMB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,946,000
- Market Cap $45.9M
- Description
- INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...